Raman Sharma

3.8k total citations
74 papers, 2.0k citations indexed

About

Raman Sharma is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Raman Sharma has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Pharmacology and 13 papers in Computational Theory and Mathematics. Recurrent topics in Raman Sharma's work include Pharmacogenetics and Drug Metabolism (17 papers), Computational Drug Discovery Methods (13 papers) and Malaria Research and Control (12 papers). Raman Sharma is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Computational Drug Discovery Methods (13 papers) and Malaria Research and Control (12 papers). Raman Sharma collaborates with scholars based in United States, United Kingdom and China. Raman Sharma's co-authors include Amit S. Kalgutkar, Gregory S. Walker, R. Scott Obach, Neil G. Berry, Heather Eng, Alfin D. N. Vaz, Paul M. O’Neill, Stephen A. Ward, Vincent Mascitti and Chandra Prakash and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and FEBS Letters.

In The Last Decade

Raman Sharma

73 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raman Sharma United States 27 785 413 349 284 233 74 2.0k
Mohamed E.M. Saeed Germany 28 1.3k 1.6× 192 0.5× 277 0.8× 247 0.9× 145 0.6× 70 2.5k
Don K. Walker United Kingdom 22 631 0.8× 148 0.4× 385 1.1× 284 1.0× 374 1.6× 40 2.2k
Anna K. Schrey Germany 14 1.0k 1.3× 718 1.7× 257 0.7× 873 3.1× 154 0.7× 24 2.5k
Andrew V. Stachulski United Kingdom 28 855 1.1× 956 2.3× 397 1.1× 180 0.6× 157 0.7× 104 2.3k
Luca Pinzi Italy 17 1.2k 1.5× 411 1.0× 285 0.8× 802 2.8× 124 0.5× 42 2.2k
Brian Springthorpe United Kingdom 5 879 1.1× 546 1.3× 223 0.6× 589 2.1× 89 0.4× 8 1.8k
Rahul Singh India 29 1.1k 1.4× 307 0.7× 222 0.6× 755 2.7× 513 2.2× 79 2.9k
Martin Smieško Switzerland 27 1.0k 1.3× 445 1.1× 261 0.7× 560 2.0× 108 0.5× 102 2.1k
Melissa F. Adasme Germany 11 1.9k 2.4× 600 1.5× 240 0.7× 1.1k 3.9× 277 1.2× 12 3.6k
Ashfaq Ur Rehman Pakistan 31 1.3k 1.7× 1.1k 2.7× 133 0.4× 528 1.9× 161 0.7× 122 2.9k

Countries citing papers authored by Raman Sharma

Since Specialization
Citations

This map shows the geographic impact of Raman Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raman Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raman Sharma more than expected).

Fields of papers citing papers by Raman Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raman Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raman Sharma. The network helps show where Raman Sharma may publish in the future.

Co-authorship network of co-authors of Raman Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Raman Sharma. A scholar is included among the top collaborators of Raman Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raman Sharma. Raman Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Raman, Matthew Dowling, Kentaro Futatsugi, & Amit S. Kalgutkar. (2023). Mitigating a Bioactivation Liability with an Azetidine-Based Inhibitor of Diacylglycerol Acyltransferase 2 (DGAT2) En Route to the Discovery of the Clinical Candidate Ervogastat. Chemical Research in Toxicology. 36(6). 934–946. 1 indexed citations
2.
Singh, Ravi Shankar Prasad, Gregory S. Walker, Eugene P. Kadar, et al.. (2022). Metabolism and Excretion of Nirmatrelvir in Humans Using Quantitative Fluorine Nuclear Magnetic Resonance Spectroscopy: A Novel Approach for Accelerating Drug Development. Clinical Pharmacology & Therapeutics. 112(6). 1201–1206. 15 indexed citations
3.
Cerny, Matthew A., Amit S. Kalgutkar, R. Scott Obach, et al.. (2020). Effective Application of Metabolite Profiling in Drug Design and Discovery. Journal of Medicinal Chemistry. 63(12). 6387–6406. 33 indexed citations
4.
Sharma, Raman, et al.. (2020). Automatic AMBU bag operating device: creating a boon for high-volume centres in low-income countries. BMJ Innovations. 6(4). 255–258. 3 indexed citations
5.
Hastings, Ian M., Diggory Hardy, Katherine Kay, & Raman Sharma. (2020). Incorporating genetic selection into individual‐based models of malaria and other infectious diseases. Evolutionary Applications. 13(10). 2723–2739. 6 indexed citations
6.
Lapham, Kimberly, Ernesto Callegari, Julie Cianfrogna, et al.. (2020). In Vitro Characterization of Ertugliflozin Metabolism by UDP-Glucuronosyltransferase and Cytochrome P450 Enzymes. Drug Metabolism and Disposition. 48(12). 1350–1363. 16 indexed citations
7.
Obach, R. Scott, Gregory S. Walker, Raman Sharma, et al.. (2018). Lead Diversification at the Nanomole Scale Using Liver Microsomes and Quantitative Nuclear Magnetic Resonance Spectroscopy: Application to Phosphodiesterase 2 Inhibitors. Journal of Medicinal Chemistry. 61(8). 3626–3640. 24 indexed citations
8.
Stepan, Antonia F., Tuan P. Tran, Christopher J. Helal, et al.. (2018). Late-Stage Microsomal Oxidation Reduces Drug–Drug Interaction and Identifies Phosphodiesterase 2A Inhibitor PF-06815189. ACS Medicinal Chemistry Letters. 9(2). 68–72. 25 indexed citations
9.
Hodel, Eva Maria, et al.. (2018). Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance. The Journal of Infectious Diseases. 219(8). 1243–1253. 7 indexed citations
10.
Brodney, Michael A., Raman Sharma, John T. Lazzaro, Gregory S. Walker, & R. Scott Obach. (2018). Harnessing biosynthesis and quantitative NMR for late stage functionalization of lead molecules: Application to the M1 positive allosteric modulator (PAM) program. Bioorganic & Medicinal Chemistry Letters. 28(11). 2068–2073. 9 indexed citations
11.
Thakare, Rhishikesh, Hongying Gao, Rachel E. Kosa, et al.. (2017). Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting Polypeptides. Drug Metabolism and Disposition. 45(7). 721–733. 38 indexed citations
12.
Ullah, Imran, Raman Sharma, Giancarlo A. Biagini, & Paul Horrocks. (2016). A validated bioluminescence-based assay for the rapid determination of the initial rate of kill for discovery antimalarials. Journal of Antimicrobial Chemotherapy. 72(3). dkw449–dkw449. 12 indexed citations
13.
Grau, Santiago, Sònia Luque, Nuria E. Campillo, et al.. (2015). Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis. Journal of Antimicrobial Chemotherapy. 70(10). 2854–2861. 58 indexed citations
14.
Sharma, Raman, John Litchfield, Karen Atkinson, et al.. (2014). Metabolites in Safety Testing Assessment in Early Clinical Development: A Case Study with a Glucokinase Activator. Drug Metabolism and Disposition. 42(11). 1926–1939. 15 indexed citations
15.
16.
Sharma, Raman, Hao Sun, David W. Piotrowski, et al.. (2012). Metabolism, Excretion, and Pharmacokinetics of ((3,3-Difluoropyrrolidin-1-yl)((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone, a Dipeptidyl Peptidase Inhibitor, in Rat, Dog and Human. Drug Metabolism and Disposition. 40(11). 2143–2161. 24 indexed citations
17.
Fisher, Nicholas, Alison Mbekeani, Alison E. Shone, et al.. (2010). A novel drug for uncomplicated malaria: Targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNDH2) of Plasmodium falciparum. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1797. 80–80. 1 indexed citations
18.
Pfefferkorn, Jeffrey A., Jihong Lou, Martha L. Minich, et al.. (2009). Pyridones as glucokinase activators: Identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle. Bioorganic & Medicinal Chemistry Letters. 19(12). 3247–3252. 66 indexed citations
19.
20.
Stresser, David M., Andrew P. Blanchard, Raman Sharma, et al.. (2004). HIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLE. Drug Metabolism and Disposition. 32(1). 105–112. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed E.M. Saeed Breakdown of academic impact, for papers by Don K. Walker Breakdown of academic impact, for papers by Anna K. Schrey Breakdown of academic impact, for papers by Andrew V. Stachulski Breakdown of academic impact, for papers by Luca Pinzi Breakdown of academic impact, for papers by Brian Springthorpe Breakdown of academic impact, for papers by Rahul Singh Breakdown of academic impact, for papers by Martin Smieško Breakdown of academic impact, for papers by Melissa F. Adasme Breakdown of academic impact, for papers by Ashfaq Ur Rehman
Rankless by CCL
2026